Atlas Trials

A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma

Clinical trial NCT06656039 · COMPLETED

Trial details

NCT number
NCT06656039
Sponsor
RenJi Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Renal Cell Carcinoma, Clear Cell
Start date
2024-01-01
Primary completion
2024-10-10
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.